HeroKi

Company Overview

Snapshot

Founded in January 2017 by Alon Magal and Fiona Choppe Magal, HeroKi operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its wearable technology.

Business overview

HeroKi develops wearable belts designed as kidney shields for post-transplant kidney recipients. These products are constructed from impact-absorbent, lightweight materials, intended to be comfortably worn both under and over clothing. The company's core technology aims to provide kidney transplant recipients with increased confidence and comfort in their daily activities. HeroKi operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices and medical treatment & therapeutics markets, serving both B2C and B2B segments globally.

Company Intelligence Q&A

What is HeroKi's primary product?

HeroKi's primary product is a wearable kidney shield designed for post-transplant kidney recipients. These belts are made from impact-absorbent, lightweight materials for comfortable wear.

When was HeroKi founded?

HeroKi was founded in January 2017.

Who are the co-founders of HeroKi?

HeroKi was co-founded by Alon Magal, who serves as CEO, and Fiona Choppe Magal, who serves as CMO.

What is HeroKi's current operational status?

HeroKi is currently non-active, having ceased operations in August 2024.

What markets does HeroKi target?

HeroKi targets global markets with its wearable kidney shield product, focusing on the needs of kidney transplant recipients.